Skip Navigation
Menu Search
Pediatric Oncology

In This Section      

Hodgkin's Disease Program

Our experts are recognized as national experts in chemotherapy and radiation therapy treatments of Hodgkin's disease. Great emphasis is placed on long-term survivors and late effects of treatment. The director of pediatric oncology is the Chairperson (CLS) for Hodgkin's Disease in the Children's Oncology Group. Johns Hopkins is leading the national Children's Oncology Group trial testing immunomodulation after bone marrow transplantation in patients with Hodgkin's disease.